The Importance of Diversity in Clinical Trials for Hepatitis C

Medically reviewed in January 2022

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

Featured Content


How to Fight an Insurance Claim Denial

Try these strategies if your insurance company denies coverage for treatment.

Why Hepatitis C is Called a "Quiet Killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.

Who Is at Risk for Hepatitis C?

Learn who has higher odds of contracting this viral infection.

Patient Perspectives: Understanding Healthcare Equity as a Provider, Patient, or Person of Color

From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.

What to Do When Hepatitis C Treatment is Denied

Take these steps to get the medication you need.